ECM1 and inflammatory bowel disease: This suggests that ECM1 in IBD promotes M1 polarization by inhibiting the GM-CSF/STAT5 pathway while also inhibiting M2 polarization, and a series of inflammatory damage responses occur because of immune imbalance.